ArticleThe Journal of veterinary medical science2025
Seroprevalence and associated risk factors of epizootic hemorrhagic disease virus in cattle from the northern region of Peru: first serological report.
Article in The Journal of veterinary medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epizootic hemorrhagic disease virus (EHDV) is a vector-borne pathogen that affects both wild and domestic ruminants. Climate influences vector-borne diseases by driving vector migration to new areas, where they spread the virus. However, the lack of surveillance in some areas hinders accurate assessment the true disease burden. This study aimed to determine the seroprevalence of EHDV and associated risk factors in cattle from the northern region of Peru in 2022. Blood serum samples were collected from 578 cattle in the departments of Tumbes, Piura, Lambayeque, Cajamarca, and La Libertad and analyzed using cELISA. The overall EHDV seroprevalence was 17.82% (95% confidence interval 14.78-21.19). The highest proportion of seropositive animals was observed in two deparments closest to the equator, Piura and Tumbes (50%), followed by Lambayeque (39.1%) and Cajamarca (11.08%). In addition, the highest seroprevalence was found at temperatures ≤20°C (50.46%), wind speeds ≤3 m/sec (31.43%), and altitudes ≤1,260 masl (37.28%), with a significant decrease at higher elevations (P<0.05). After adjusting for temperature, the odds of EHDV seropositivity were significantly lower in cattle from areas located at >2,000 to ≤3,290 masl (Odds ratio [OR]=0.15) and >3,290 (OR=0.07), compared to those from the reference altitude category of ≤1,260 masl. Similarly, after adjusting for altitude, cattle from deparments with temperatures >20°C had significantly lower odds of seropositivity (OR=0.17) compared to those exposed to temperatures ≤20°C. This study reports anti-EHDV antibodies in cattle from northern Peru for the first time, highlighting associations with bioclimatic factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.